For most people, IVF has roughly a 30% to 45% chance of resulting in a baby after the first cycle, depending primarily on age. The national U.S. live birth rate for a first embryo transfer using the patient’s own eggs is about 39% for women under 35, dropping to around 11% for women aged 41 to 42. Those numbers are real and worth understanding in detail, because “first time” can mean different things, and several factors shift the odds significantly.
First-Cycle Success Rates by Age
Age is the single strongest predictor of whether IVF will work on the first attempt. The 2023 national data from the Society for Assisted Reproductive Technology (SART) breaks down live birth rates per first embryo transfer using the patient’s own eggs:
- Under 35: 39.4%
- 35 to 37: 31.0%
- 38 to 40: 21.3%
- 41 to 42: 11.3%
- Over 42: 3.7%
These figures reflect all patients in those age brackets, regardless of diagnosis or clinic. Your individual odds could be higher or lower depending on the specifics of your situation. But the pattern is consistent across large datasets worldwide: egg quality declines with age, and that decline accelerates sharply after 40. A 34-year-old and a 41-year-old going through the exact same protocol will have very different outcomes.
How Genetic Testing Changes the Numbers
When embryos are screened for chromosomal abnormalities before transfer (a process called PGT-A), first-transfer success rates climb substantially. The 2022 SART data for frozen embryo transfers with PGT-A shows a striking pattern: success rates hold much more steady across age groups compared to transfers without screening.
- Under 35 with PGT-A: 54.5% live birth rate
- 35 to 37 with PGT-A: 53.2%
- 38 to 40 with PGT-A: 51.4%
- 41 to 42 with PGT-A: 49.9%
- Over 42 with PGT-A: 46.3%
The reason the age gap narrows so dramatically is that PGT-A filters out chromosomally abnormal embryos before they’re transferred. A 41-year-old produces far more abnormal embryos than a 30-year-old, but if a normal embryo is identified and transferred, it has a similar chance of implanting. The catch is that older patients often have fewer embryos to screen, so they may need more egg retrieval cycles to find a normal one. One study found that clinical pregnancy after the first embryo transfer occurred in 82% of the PGT-A group compared to 70% of the control group for women over 35.
PGT-A adds cost and requires freezing embryos while awaiting results, so it’s not automatically recommended for everyone. But for patients over 35 or those with a history of miscarriage, it can meaningfully improve the odds that a given transfer will succeed.
Fresh Versus Frozen Transfers
Whether your embryo is transferred fresh (during the same cycle as egg retrieval) or frozen and transferred later can also affect first-time outcomes, though the answer isn’t as simple as “one is always better.” For most patients with a good prognosis, frozen and fresh transfers produce similar results, and many clinics now default to freezing because it allows time for genetic testing and lets the uterine lining recover from stimulation medications.
However, for patients with a lower chance of success, fresh transfers may have an edge. A study of 838 women aged 33 to 34 with a low prognosis found that 40% of women in the fresh transfer group had a live birth compared to 32% in the frozen group. The cumulative live birth rate within one year was also higher for the fresh group: 51% versus 44%. This suggests that the freezing and thawing process may matter more when embryo quality is already marginal.
Pregnancy Test Versus Live Birth
One thing that trips people up when researching IVF statistics is the difference between a positive pregnancy test and an actual baby. Clinics may report “clinical pregnancy rates,” which count any pregnancy confirmed by ultrasound around five weeks after transfer. Live birth rates are always lower.
Some pregnancies that register as positive on a blood test never progress far enough to show a gestational sac on ultrasound. These are called biochemical pregnancies, and research suggests roughly half of all failed pregnancies happen at this preclinical stage. Others end in miscarriage after a heartbeat is detected. When you’re comparing clinics or reading success statistics, make sure you’re looking at live birth rates, not pregnancy rates. The gap between the two can be 10 percentage points or more.
What Cumulative Cycles Look Like
If IVF doesn’t work the first time, the odds of eventually taking home a baby increase with each additional cycle. Australian data tracking thousands of women who started IVF in 2016 and 2017 shows how the numbers build:
- Under 30: 43% after one cycle, 66% after three
- 30 to 31: 48% after one cycle, 67% after three
- 34 to 35: 40% after one cycle, 61% after three
- 38 to 39: 22% after one cycle, 38% after three
- 42 to 43: 6% after one cycle, 11% after three
For women under 35, three cycles bring the cumulative chance of a baby to around two in three. That’s a meaningful improvement over a single attempt and one reason fertility specialists often talk about IVF as a process rather than a one-shot procedure. Each cycle also gives your medical team more information about how your body responds to medications, which can help them fine-tune the approach.
That said, the cumulative benefit is smaller for older patients. A woman over 42 who doesn’t succeed in the first cycle has only modestly better odds after two more. At some point, the conversation may shift toward donor eggs, which carry the success rates associated with the donor’s age rather than the patient’s.
Why AMH Levels Don’t Predict Success Well
If you’ve had your ovarian reserve tested, you probably received an AMH (anti-Müllerian hormone) number. AMH reliably predicts how many eggs your ovaries will produce in response to stimulation medications, which matters for planning your protocol. But it turns out to be a surprisingly poor predictor of whether IVF will actually result in a pregnancy.
A recent analysis found that AMH had an accuracy score of roughly 0.49, which is essentially no better than a coin flip for predicting pregnancy outcomes. The same was true for antral follicle count, number of eggs retrieved, and most measures of embryo quality. Even women with low AMH (below 1.0 ng/mL) achieved pregnancies, though they typically produced fewer eggs per cycle. A low AMH means you may need a more tailored stimulation plan and could have fewer embryos to work with, but it doesn’t mean IVF won’t work for you.
Factors That Actually Move the Needle
Beyond age and genetic testing, a few other variables influence first-cycle success. Body weight plays a role: both very low and very high BMI are associated with lower implantation rates, likely because of hormonal effects on the uterine lining. Smoking reduces IVF success rates measurably, and most clinics strongly recommend quitting before starting treatment.
The underlying cause of infertility matters too. Patients with blocked fallopian tubes but otherwise normal egg quality tend to do well with IVF, since the procedure bypasses the tubes entirely. Male factor infertility, where sperm quality is the primary issue, also responds well to IVF with sperm injection. Conditions like endometriosis or diminished ovarian reserve introduce more variability.
Clinic choice also matters more than people realize. Success rates vary significantly between clinics, even after adjusting for patient demographics. SART publishes clinic-level data that lets you compare live birth rates, though it’s worth noting that clinics treating more difficult cases may have lower headline numbers without being worse at what they do.